Regulation of the mouse mammary tumor virus receptor by phosphorylation and internalization in mammary epithelial cells
β Scribed by Franklyn F. Bolander JR.
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 605 KB
- Volume
- 161
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
β¦ Synopsis
The mouse mammary tumor virus enters mammary epithelial cells via a plasma membrane protein that binds to a viral envelope glycoprotein, gp52. In intact cells, this gp52 receptor can be phosphorylated by activators of protein kinase A and protein kinase C (PKC), but this modification does not occur in response to epidermal growth factor, whose receptor is a tyrosine kinase, or to gp52. Phosphorylation of the gp52 receptor rapidly leads to internalization and gradual loss of binding activity. Both the phosphorylation and the internalization induced by PKC are abolished by prior downregulation of this kinase. Although the physiological function of the gp52 receptor is unknown, its binding to gp52 can stimulate several biological activities, including amino acid accumulation. Receptor processing impairs this gp52-induced amino acid uptake, as well as viral infection, by depleting the binding protein at the cell surface. In contrast, PKC augments insulin-induced amino acid transport, and PKC downregulation abolishes the action of insulin, suggesting that insulin and gp52 utilize partially separate pathways leading to amino acid transport. These data further suggest that PKC may be involved in this insulin-stimulated activity.
π SIMILAR VOLUMES
## Abstract Abnormalities in the interactions of cells with the extracellular matrix (ECM) play an important role in the development and progression of many types of cancer and are a hallmark of malignant transformation. The dystroglycan (DG) complex is a transmembrane glycoprotein that forms a con
## Abstract The inappropriate activation of one or more members of the ErbB family of receptor tyrosine kinases [ErbBβ1 (EGFR), ErbBβ2, ErbBβ3, ErbBβ4] has been linked with oncogenesis. ErbBβ2 is frequently coexpressed with ErbBβ3 in breast cancer cells and in the presence of the ligand heregulin (
## Abstract Methylseleninic acid (MSeA) is a synthetic organoselenium form known to be effective against mammary carcinogenesis __in vivo__. Using the synchronized mouse mammary epithelial tumor cell (TM6) model, we have previously shown that 5 ΞΌM MSeA significantly inhibits cell growth and induces
## Abstract The following strains have been bred and developed for mammary tumor studies in this laboratory; C3H, C3HfB, C3HfDD, C3HβA^vy^, C3HβA^vy^fB, DD, DDfB, DDfC3H, BALB/c, BALB/cfDD, BALB/cfC3H, A (High), A (Low), AfB, and C57BL. Data are presented on mammary tumor incidence and age, occurre